The intestinal immune system responds to soluble antigens with tolerance, although some antigens can induce protective immunity. Key to the oral immunogenicity of these rare antigens is receptor-mediated transcytosis. We intend to elucidate the function of the transcytosis process in the induction of intestinal immunity and how this process can be modulated to improve mucosal vaccines targeted to transcytotic receptors.